Regulatory landscape and challenges in CAR-T cell therapy development in the US, EU, Japan, and India.
- DOI
- 10.1016/j.ejpb.2024.114361
- Published
- 2024 Aug
- Container
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejpb.2024.114361,
title = {Regulatory landscape and challenges in CAR-T cell therapy development in the US, EU, Japan, and India.},
author = {S S KD and Joga R and Srivastava S and Nagpal K and Dhamija I and Grover P and Kumar S},
year = {2024},
journal = {European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V},
doi = {10.1016/j.ejpb.2024.114361},
url = {https://doi.org/10.1016/j.ejpb.2024.114361}
}RIS
TY - JOUR TI - Regulatory landscape and challenges in CAR-T cell therapy development in the US, EU, Japan, and India. AU - S S KD AU - Joga R AU - Srivastava S AU - Nagpal K AU - Dhamija I AU - Grover P AU - Kumar S PY - 2024 JO - European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V DO - 10.1016/j.ejpb.2024.114361 UR - https://doi.org/10.1016/j.ejpb.2024.114361 ER -
APA
KD, S. S., R, J., S, S., K, N., I, D., P, G., & S, K. (2024). Regulatory landscape and challenges in CAR-T cell therapy development in the US, EU, Japan, and India.. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. https://doi.org/10.1016/j.ejpb.2024.114361
Source records
- pubmed · retrieved 2026-09-26T18:48:51.687Z